Is it necessary to stop glucagon-like peptide-1 receptor agonists prior to endoscopic procedure? A retrospective study.
在內視鏡程序前是否有必要停止使用胰高血糖素樣肽-1受體激動劑?一項回顧性研究。
World J Gastroenterol 2024-08-01
Real-World Impact of GLP-1 Receptor Agonists on Endoscopic Patient Outcomes in an Ambulatory Setting: A Retrospective Study at a Large Tertiary Center.
GLP-1 受體激動劑對門診患者內視鏡結果的實際影響:大型三級醫療中心的回顧性研究。
J Clin Med 2024-09-28
A Scoping Review of GLP-1 Receptor Agonists: Are They Associated with Increased Gastric Contents, Regurgitation, and Aspiration Events?
GLP-1 受體激動劑的範疇回顧:它們是否與胃內容物增加、逆流和吸入事件相關?
J Clin Med 2024-11-09
Evidence Report on the Safety of Gastrointestinal Endoscopy in Patients on Glucagon-like Peptide-1 Receptor Agonists: A Systematic Review and Meta-Analysis.
使用 Glucagon-like Peptide-1 受體激動劑患者的胃腸內視鏡安全性證據報告:系統性回顧與統合分析。
Diagnostics (Basel) 2025-03-28
A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general anesthesia.
深度鎮靜或全身麻醉前的胰高血糖素樣肽-1受體激動劑敘述性綜述。
J Anesth Analg Crit Care 2025-03-29